Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
ISIS-APOCIIIRx (ISIS 304801)
Also known as: APOC-III antisense inhibitor
print preview
bookmark
share with colleague
General Information
Company
Isis Pharmaceuticals Inc.
Description
Apolipoprotein C-III (APOC3) antisense inhibitor
Molecular Target
Apolipoprotein C-III (APOCIII) (APOC3)
Mechanism of Action
Antisense therapy
Latest Stage of Development
Phase II
Indication
Hypertriglyceridemia
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy